MN HF 4881
died on adjournmentPrescription Drug Affordability Advisory Council eliminated, nondepository financial institution provisions modified, health plan regulatory alignment provided, duties transferred, premium security plan modified, appropriations reduced, and money appropriated.
Minnesota · 2025-2026 · lower
Quick answers
Did MN HF 4881 pass?
No. MN HF 4881 died when the 2025-2026 session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-04-09): Introduction and first reading, referred to Rules and Legislative Administration
What is MN HF 4881 about?
MN HF 4881 is a bill in the 2025-2026 titled “Prescription Drug Affordability Advisory Council eliminated, nondepository financial institution provisions modified, health plan regulatory alignment provided, duties transferred, premium security plan modified, appropriations reduced, and money appropriated.”.
Who sponsors MN HF 4881?
Koegel is the primary sponsor of MN HF 4881.
- Introduced
- 2026-04-09
- Latest action
- 2026-04-09 — Introduction and first reading, referred to Rules and Legislative Administration
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Koegelprimary
Committees
Not provided by source.
Action timeline
2026-04-09
Introduction and first reading, referred to Rules and Legislative Administration
introduction,referral-committee
Versions
- Introduction — 2026-04-08Compare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: SF 5046
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:24:48.331508Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MN&identifier=HF 4881. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.